Therapeutics and COVID-19 - A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Morten H. Møller; Michelle S. Chew; Klaus T. Olkkola; Marius Rehn; Arvi Yli-Hankala; Martin I. Sigurðsson

doi:10.1111/aas.14046

Therapeutics and COVID-19 - A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Morten H. Møller^*, Michelle S. Chew, Klaus T. Olkkola, Marius Rehn, Arvi Yli-Hankala, Martin I. Sigurðsson

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

3 Citationer (Scopus)

8 Downloads (Pure)

Abstract

The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

Originalsprog	Engelsk
Tidsskrift	Acta Anaesthesiologica Scandinavica
Vol/bind	66
Udgave nummer	5
Sider (fra-til)	636-637
Antal sider	2
ISSN	0001-5172
DOI	https://doi.org/10.1111/aas.14046
Status	Udgivet - 2022

Bibliografisk note

Funding Information:
Funding was provided from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine and institutional and/or departmental sources.

Publisher Copyright:
© 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.

Adgang til dokumentet

10.1111/aas.14046Licens: CC BY

FulltextForlagets udgivne version, 358 KBLicens: CC BY

Citationsformater

Therapeutics and COVID-19 - A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. / Møller, Morten H.; Chew, Michelle S.; Olkkola, Klaus T.; Rehn, Marius; Yli-Hankala, Arvi; Sigurðsson, Martin I.

I: Acta Anaesthesiologica Scandinavica, Bind 66, Nr. 5, 2022, s. 636-637.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{dbab108b72f045e6add69d8c1d81b186,

title = "Therapeutics and COVID-19 - A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine",

abstract = "The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.",

keywords = "AGREE II, clinical practice guideline, COVID-19, therapeutics, WHO",

author = "M{\o}ller, {Morten H.} and Chew, {Michelle S.} and Olkkola, {Klaus T.} and Marius Rehn and Arvi Yli-Hankala and Sigur{\dh}sson, {Martin I.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.",

year = "2022",

doi = "10.1111/aas.14046",

language = "English",

volume = "66",

pages = "636--637",

journal = "Acta Anaesthesiologica Scandinavica",

issn = "0001-5172",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Therapeutics and COVID-19 - A living WHO guideline

T2 - Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

AU - Møller, Morten H.

AU - Chew, Michelle S.

AU - Olkkola, Klaus T.

AU - Rehn, Marius

AU - Yli-Hankala, Arvi

AU - Sigurðsson, Martin I.

PY - 2022

Y1 - 2022

N2 - The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

AB - The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

KW - AGREE II

KW - clinical practice guideline

KW - COVID-19

KW - therapeutics

KW - WHO

U2 - 10.1111/aas.14046

DO - 10.1111/aas.14046

M3 - Journal article

C2 - 35170027

AN - SCOPUS:85125900433

VL - 66

SP - 636

EP - 637

JO - Acta Anaesthesiologica Scandinavica

JF - Acta Anaesthesiologica Scandinavica

SN - 0001-5172

IS - 5

ER -